BioGeneration Ventures manages funds that are actively investing venture capital in the next generation of successful life sciences companies in The Netherlands, Belgium and Germany.
We focus on high potential companies active in healthcare, therapeutics, medical devices, diagnostics and novel food applications. The team of BioGeneration Ventures has a successful track record and a broad experience in the life sciences sector. Our involvement goes beyond only a financial investment. Having been entrepreneurs ourselves our strategy is to generate value by working very closely with our portfolio companies and provide active hands-on support.
BioGeneration Ventures launched its first fund in 2006 backed by a broad international and strategic LP-base from its start. Initial funding came from the Netherlands Genomics Initiative (NGI) and the Netherlands Organization for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO as lead investors. Today we are managing 3 funds with a growing portfolio of investments. We have realized four exits and are actively investing from our most recent fund that made its first investment in May of 2012. BioGeneration is based in Naarden, The Netherlands.